Alternatives to Developmental Genotype-Tissue Expression Project

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Space BioTech startup developing an autonomous, high-throughput screening platform for drug discovery in microgravity.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.

AI-powered drug discovery company focused on neurological and neuromuscular diseases, leveraging transcriptomics to accelerate therapeutic development.

Revolutionizing genomic analysis with innovative sequencing technology.

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Developing oral small molecule medicines for immunological and chronic diseases.

Advancing next-generation mRNA medicines.

Developing novel therapies to reverse aging and extend lifespan.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Unlocking industrial-scale RNA-seq for primary drug screening and toxicology.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

Scalable, one-time curative in-vivo gene editing therapies.

Accelerating breakthroughs in prostate cancer diagnosis and treatment.

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

AI-enabled technology for cell biology research and biopharma development.

AI-driven biotechnology company developing novel protein therapeutics through generative biology.

Developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Developing disease-responsive advanced therapies through programmable gene control technology.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Developing breath-based diagnostics for lung diseases.

A de-extinction biotechnology company aiming to revive extinct species.

Developing an automated platform for liquid biopsy sample preparation.

Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Developing novel therapeutics to restore gut lymphatic function.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Enzyme-based technology to break down alcohol in the stomach.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.

A leading organization dedicated to curing and treating cystic fibrosis.

A global leader in clinical pharmacology and bioanalytical sciences.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Developing novel immunotherapies and diagnostics for cancer.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.